MedPath

Comparison of 3 Methods to Diagnose Endolymphatic Hydrops in Meniere's Disease

Not Applicable
Completed
Conditions
Endolymphatic Hydrops
Interventions
Diagnostic Test: MRI 3T
Registration Number
NCT03215420
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

The aim of this study is to compare 3 methods for the diagnosis of endolymphatic hydrops (EH) in patients with Meniere's disease: MRI 3 Tesla (to visualise EH directly), and functional explorations, namely electrocochleography and dephasing of acoustic distortion products (which are modified by the EH).

The research hypothesis is that the examinations will show agreement in the diagnosis of EH, and that the results obtained (quantitative values) will vary in the same direction over time and during flares of MD.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • persons who have provided written consent
  • persons aged 18 to 75 years
  • persons with certain, probable or possible Meniere's disease according to the international classification AAO-HNS
Exclusion Criteria
  • persons without health insurance cover
  • adults under guardianship
  • persons with a history of hypersensitivity to the active substance or to one of the excipients of the contrast agent used for the MRI or to any gadolinium chelate
  • pregnant or breast-feeding women
  • severe acute or chronic kidney failure
  • other identified causes of cochleo-vestibular syndromes
  • Impossibility to follow-up or carry out any of the examinations necessary for the protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Certain or probable Meniere's diseaseMRI 3T-
Primary Outcome Measures
NameTimeMethod
Number of patients for whom an endolymphatic hydrops was diagnosed by electrocochleographyday one
Number of patients for whom an endolymphatic hydrops was diagnosed by (Dephasing) of acoustic distortion productsday one
Number of patients for whom an endolymphatic hydrops was diagnosed by 3T MRI 3Tday one
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHu Dijon Bourgogne

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath